Back to Authors

Simard, J. Marc

0000-0002-5373-1988

Mayo Clinic

University of Maryland, Baltimore

Citations 2

Emerging therapeutic targets for cerebral edema
Raikwar, Sudhanshu P. , Mihaljević, Sandra, Casabella, Amanda M., Rani, Anupama , Gerzanich, Volodymyr , Raikwar, Sudhanshu , Jha, Ruchira Menka , Catapano, Joshua S , Desai, Shashvat M. , Simard, J. Marc

Expert Opinion on Therapeutic Targets | November 30, 2021 | Volume: 25 | Issue: 11 | Pages: 917-938

10.1080/14728222.2021.2010045 Get It

Recommendations of the National Heart, Lung, and Blood Institute Working Group on Cerebrovascular Biology and Disease
Iadecola, Costantino , Goldman, Stephen S., Harder, David R., Katušić, Zvonimir S. , Moskowitz, Michael A. , Sloan, Michael A., Traystman, Richard J., Velletri, Paul A., Heistad, Donald D. , Simard, J. Marc

Stroke | April 21, 2006 | Volume: 37 | Issue: 6 | Pages: 1578-1581

10.1161/01.str.0000221297.57305.8a Get It

The National Heart, Lung, and Blood Institute (NHLBI) convened a conference call working group, consisting of experts in stroke and cerebrovascular biology on January 28, 2005. The purpose of this working group was to develop a prioritized set of recommendations for NHLBI to establish a focused and comprehensive set of research activities in cerebrovascular biology and disease. Three thematic areas of research emerged: (1) molecular and cellular neurobiology of cerebral blood vessels, focusing on genomics and proteomics, neurovascular signaling and cerebrovascular embryogenesis, development and plasticity; (2) resource development, involving the development of new methodological approaches for normal and altered function of the neurovascular unit, collaborative research, and training in cerebrovascular pathobiology; and (3) cerebrovascular diseases and translational approaches, addressing vascular mechanisms of disease, the role of risk factors, importance of biomarkers with the ultimate goal of developing new treatments.